溶瘤生物科技 ONCY 深 沪
已收盘 02-06 16:00:00 美东时间
0.8859
+0.049
+5.89%
华盛通- 最 高0.9065
- 今 开0.82
- 成交量 146.19万股
- 最 低 0.82
- 昨 收 0.8366
- 总市值 9532.85万
- 52周最高 1.51
- 市盈率 静 --
- 换手率 1.36%
- 52周最低 0.3258
- 委 比 18.89%
- 总股本 1.08亿
- 历史最高 6.037
- 量 比 0.55
- 振 幅 10.34%
- 历史最低 0.3258
- 每 手 1
- 风险率 0.28%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Oncolytics Biotech receives FDA Fast Track for pelareorep
An update from Oncolytics Biotech ( ($ONCY) ) is now available. On February 4, ...
02-05 01:28
FDA Grants Fast Track Designation to Oncolytics Biotech's Pelareorep for KRAS-Mutant MSS Metastatic Colorectal Cancer
FDA Grants Fast Track Designation to Oncolytics Biotech's Pelareorep for KRAS-Mutant MSS Metastatic Colorectal Cancer Oncolytics Biotech Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to pelareorep in combination with bevacizumab (Avastin®) and FOL
02-04 21:50
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium
Issued on behalf of Oncolytics Biotech Inc. Equity-Insider.com News Commentary VANCOUVER, BC, Jan. 30, 2026 /PRNewswire/ -- The oncology sector is undergoing a massive capital rotation driv...
01-30 23:36
$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 30, 2026 /PRNewswire/ -- The global oncology sector is rocketing toward $668 billion in 2034[...
01-30 23:19
Oncolytics Biotech® Announces Results of Special Meeting of Shareholders
Oncolytics Biotech Inc. announced the results of its Special Meeting of Shareholders, where all resolutions were approved. The Continuance Resolution (85.21% for) authorizes the Company to move from Alberta to British Columbia. The Domestication Resolution (86.98% for) allows it to relocate to Nevada. The 2026 Incentive Award Plan Resolution (76.77% for) approves the new incentive plan, contingent on the completion of the Continuance and Domestic...
01-15 21:01
Wall Street Analysts Are Bullish on Top Healthcare Picks
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
01-13 22:50
Oncolytics Biotech Intends To Change Jurisdiction Of Incorporation To Nevada
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today provided additional context regarding its previously announced proposal to
01-09 22:07
Oncolytics Biotech Anticipates Final Action For Its Track 1 Prioritized Examination Patent Application With U.S. PTO In Q4
Oncolytics Biotech® Inc. (Nasdaq: ONCY) ("Oncolytics" or the "Company"), a clinical-stage immunotherapy company developing pelareorep, today provided an update on the status of its intellectual property ("IP")
01-08 22:09
How $594B in Precision Tech is Cracking the Metastatic Cancer Code
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News Commentary VANCOUVER, BC, Jan. 7, 2026 /PRNewswire/ -- The global cancer drugs market is surging toward $594.3 billion by 2...
01-07 23:32
Smart Oncology: 5 Stocks Chasing the $317B Prize
Issued on behalf of Oncolytics Biotech Inc. USANewsGroup.com News Commentary VANCOUVER, BC, Dec. 31, 2025 /PRNewswire/ -- The precision oncology market surged to $139.4 billion in 2025 and i...
2025-12-31 20:25
